Page last updated: 2024-08-23

mefloquine and glycerophosphoinositol 4,5-bisphosphate

mefloquine has been researched along with glycerophosphoinositol 4,5-bisphosphate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aréchiga-Figueroa, IA; Ferrer, T; López-Izquierdo, A; Moreno-Galindo, EG; Ponce-Balbuena, D; Rodríguez-Martínez, M; Rodríguez-Menchaca, AA; Sánchez-Chapula, JA1

Other Studies

1 other study(ies) available for mefloquine and glycerophosphoinositol 4,5-bisphosphate

ArticleYear
The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:4

    Topics: Animals; Antimalarials; Cats; HEK293 Cells; Humans; Inhibitory Concentration 50; KATP Channels; Mefloquine; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphatidylinositol 4,5-Diphosphate; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying

2011